High impact information on Thermoluminescent Dosimetry

• Whole body dose measurements were made using lithium fluoride thermoluminescent dosimetry [1].
• METHODS AND MATERIALS: Using a polystyrene miniphantom embedded in cork or cedar, thermoluminescent dosimetry and film dosimetry was performed to investigate interface effects and the central dose per monitor unit (MU) [2].
• The dose-rate distributions about the applicator were determined using a combination of thermoluminescent dosimetry (TLD-100 detectors) and radiochromic film dose measurement techniques along with Monte Carlo dosimetry calculations [3].
• Dose measurements using lithium fluoride thermoluminescent dosimetry indicate that the internal anal shield reduces the dose to the uninvolved anal wall by up to a factor of two while leaving the dose to the primary tumor site unaffected [4].
• In 51 patients, doses were measured at several points over the treated breast using Thermoluminescent Dosimetry (TLD) at the time of the iridium implant and during the subsequent external beam therapy [5].

Biological context of Thermoluminescent Dosimetry

• In addition to the doses determined monthly by the South African Bureau of Standards' Radiation Protection Service (SABS), radiation doses received to the hands and whole body were measured every week using lithium fluoride thermoluminescent dosimetry (TLD) [6].

Associations of Thermoluminescent Dosimetry with chemical compounds

• Thermoluminescent dosimetry in a polystyrene phantom demonstrates that approximately 10% higher doses are delivered to the bladder, rectum, and point A with an MC system as compared to an RC system, for constant exposure in mgh [7].
• Dose rates from 110 to 165 cGy/pulse were measured using ionization chamber, ferrous sulphate and thermoluminescent dosimetry, and water calorimetry [8].
• A thermoluminescent dosimetry system was utilized to investigate how much the radiation dose is reduced through the addition of a niobium-based accessory filter to an X-ray unit's conventional aluminum filter [9].

Gene context of Thermoluminescent Dosimetry

• Lithium fluoride thermoluminescent dosimetry chips (TLD chips) were placed in the assumed intrauterine fetal position in a Rando Phantom [10].
• Individual given doses which would deliver the most uniform dose along the midline of the treatment volume were determined by computer and were verified experimentally by thermoluminescent dosimetry [11].

References